These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22686617)

  • 21. Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria.
    Rodríguez M; Vozmediano V; García-Bea A; Novák Z; Yáñez A; Campo C; Labeaga L
    Eur J Pediatr; 2020 May; 179(5):801-805. PubMed ID: 31919579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
    Bartra J; Mullol J; Montoro J; Jáuregui I; del Cuvillos A; Dávila I; Ferrer M; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():24-33. PubMed ID: 22185047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
    Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
    Bachert C; Maurer M
    Clin Drug Investig; 2010; 30(2):109-22. PubMed ID: 20067329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis.
    Passalacqua G; Canonica GW
    Clin Ther; 2005 Jul; 27(7):979-92. PubMed ID: 16154477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antihistaminics. Side effects also after raising dosage at the placebo level].
    MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis.
    Simons FE; Prenner BM; Finn A;
    J Allergy Clin Immunol; 2003 Mar; 111(3):617-22. PubMed ID: 12642846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
    Stübner P; Zieglmayer R; Horak F
    Curr Med Res Opin; 2004 Jun; 20(6):891-902. PubMed ID: 15200748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine.
    Wang XY; Lim-Jurado M; Prepageran N; Tantilipikorn P; Wang de Y
    Ther Clin Risk Manag; 2016; 12():585-97. PubMed ID: 27110120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study.
    Yonekura S; Okamoto Y; Sakurai D; Iinuma T; Sakurai T; Yoneda R; Kurita J; Hanazawa T; Kawasaki Y
    Int Arch Allergy Immunol; 2019; 180(4):274-283. PubMed ID: 31618733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bilastine upon nasal obstruction.
    Dávila I; Sastre J; Mullol J; Montoro J; Jáuregui I; Ferrer M; del Cuvillo A; Bartra J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():2-8. PubMed ID: 22185044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders.
    DuBuske LM
    Expert Opin Pharmacother; 2005 Nov; 6(14):2511-23. PubMed ID: 16259582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
    MMW Fortschr Med; 2003 May; 145(22):51. PubMed ID: 12866281
    [No Abstract]   [Full Text] [Related]  

  • 34. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis.
    Lee CF; Sun HL; Lu KH; Ku MS; Lue KH
    Pediatr Allergy Immunol; 2009 Aug; 20(5):493-9. PubMed ID: 19175892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
    Van Cauwenberge P; De Belder T; Sys L
    Expert Opin Pharmacother; 2004 Aug; 5(8):1807-13. PubMed ID: 15264995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
    Yagami A; Furue M; Togawa M; Saito A; Hide M
    J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.
    Bachert C; van Cauwenberge P
    Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double-blind, parallel group, randomized controlled trial.
    Podder I; Das A; Ghosh S; Biswas D; Sengupta S; Chowdhury SN
    Dermatol Ther; 2020 Nov; 33(6):e13946. PubMed ID: 32618048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacotherapy of urticaria--an analysis of the discrepancies between guidelines of expert bodies, registration documents and evidence for the effectiveness of drugs].
    Plichta D; Spiewak R
    Przegl Lek; 2013; 70(12):1015-20. PubMed ID: 24720119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.